| CODE | PHR2306 | ||||||||||||
| TITLE | Pharmaceutics 2 | ||||||||||||
| UM LEVEL | 02 - Years 2, 3 in Modular Undergraduate Course | ||||||||||||
| MQF LEVEL | 5 | ||||||||||||
| ECTS CREDITS | 7 | ||||||||||||
| DEPARTMENT | Pharmacy | ||||||||||||
| DESCRIPTION | Formulation development and drug delivery systems: highlights of advantages and disadvantages, considerations in meeting regulations, EU directives and harmonised standards during manufacturing and distribution. Veterinary pharmaceutical aspects: considerations in delivery systems and dosage forms used for medicines intended for veterinary use, review of highlights of veterinary pharmaceutical regulations in this context. Kinetics: application of kinetics studies including appreciation of rates of reactions in pharmaceutics. Practical experience: introduction to good manufacturing practice application in pharmaceutical industry sites and pharmaceutical compounding of dosage forms. Study-Unit Aims: - To provide students with a comprehensive insight and clear understanding of the properties and aspects of ingredients considered in the formulation of medicinal products; - To expose application of principles of kinetics in pharmaceutical technology and dosage forms development; - To explore pharmaceutical regulations regarding medicines for veterinary use. Learning Outcomes: 1. Knowledge & Understanding: By the end of the study-unit the student will be able to: - explain how properties of materials influence choice of formulating a drug delivery system; - describe properties of individual preparations and dosage forms including medical gases; - recognise factors that influence kinetics of a reaction; - discuss pharmaceutical regulations for medicines for veterinary use. 2. Skills: By the end of the study-unit the student will be able to: - compare characteristics of different drug delivery systems; - interpret kinetic data for reactions; - appraise formulation characteristics in drug delivery systems; - apply compounding techniques to formulation of medicinal products; - recognise salient practices in the pharmaceutical industry related to dosage forms manufacturing. Main Text/s and any supplementary readings: Main Texts: - Sinko PJ. Martin's physical pharmacy and pharmaceutical sciences. 6th ed. USA: Lippincott Williams and Wilkins. 2011. Supplementary Readings: - British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare products Regulatory Agency. British Pharmacopoeia. London: The Stationery Office. 2020. - Gennaro, A, Remington: The Science and Practice of Pharmacy. 22nd ed USA: Lippincott Williams & Wilkins. 2013. - Allen, L.. Ansel鈥檚 Pharmaceutical Dosage Forms and Drug Delivery Systems.11th ed. Williams & Wilkins. 2018. - Sinko PJ. Martin's physical pharmacy and pharmaceutical sciences. 7th ed. USA: Lippincott Williams and Wilkins. 2016. |
||||||||||||
| RULES/CONDITIONS | Before TAKING THIS UNIT YOU MUST TAKE PHR1301 | ||||||||||||
| ADDITIONAL NOTES | Please note that a pass in the Practical component is obligatory for an overall pass mark to be awarded. | ||||||||||||
| STUDY-UNIT TYPE | Lecture, Practical and Fieldwork | ||||||||||||
| METHOD OF ASSESSMENT |
|
||||||||||||
| LECTURER/S | Nicolette Sammut Bartolo Edwina V. Brejza Dianne Butler Marie Claire Zammit |
||||||||||||
|
The University makes every effort to ensure that the published Courses Plans, Programmes of Study and Study-Unit information are complete and up-to-date at the time of publication. The University reserves the right to make changes in case errors are detected after publication.
The availability of optional units may be subject to timetabling constraints. Units not attracting a sufficient number of registrations may be withdrawn without notice. It should be noted that all the information in the description above applies to study-units available during the academic year 2025/6. It may be subject to change in subsequent years. |
|||||||||||||